Background/Objectives: The incidence of Ceftazidime/Avibactam (CZA)-resistant Klebsiella pneumoniae isolate co-producing Klebsiella pneumoniae carbapenemase 2 (KPC-2) and Vietnamese extended-spectrum β-lactamase 25 (VEB-25) has been on the rise in Greece over the past five years. This study investigates the isolation of ST323 K. pneumoniae isolates co-resistant to CZA and cefiderocol (FDC) from colonized and infected patients in a single hospital in Athens. Methods: CZA-resistant K. pneumoniae strains were isolated from 5 ICU patients from 27 December 2023 to 22 January 2024. Antimicrobial susceptibility was tested against a panel of agents. Whole-genome sequencing of the isolates was carried out to identify the acquired resistance genes and mutations that were associated with CZA and FDC resistance. Results: The K. pneumoniae isolates belonged to ST323 and harbored bla(KPC-2) and bla(VEB-25). The isolates had a minimum inhibitory concentration (MIC) of >256 mg/L for CZA and 32 mg/L for FDC, due to the disrupted catecholate siderophore receptor Fiu. bla(VEB-25) was located on an IncC non-conjugative plasmid and on a ~14 kb multidrug resistance (MDR) region comprising 15 further acquired resistance genes. Transformation studies showed that the bla(VEB-25)-carrying plasmid provided resistance to most of the β-lactams tested, including CZA. The isolates remained susceptible to carbapenems, imipenem/relebactam, and meropenem/vaborbactam. The plasmid harbored the citrate-dependent iron (III) uptake system (fecIRABCDE), which increased the MIC of FDC from â¤0.08 mg/L to 2 mg/L. Conclusions: The bla(VEB-25) gene was associated with IncC plasmids which are important contributors to the spread of key antibiotic resistance genes. Strict infection control measures must be elaborated upon to prevent the spread of extensively drug-resistant organisms such as those described here.
Outbreak of High-Risk Clone ST323 Klebsiella pneumoniae Resistant to Ceftazidime-Avibactam Due to Acquisition of bla(VEB-25) and to Cefiderocol Due to Mutated fiu Gene.
由于获得 bla(VEB-25) 对头孢他啶-阿维巴坦耐药,以及由于 fiu 基因突变对头孢地洛耐药,导致高危克隆 ST323 肺炎克雷伯菌爆发
阅读:14
作者:Galani Irene, Karaiskos Ilias, Souli Maria, Papoutsaki Vassiliki, Gkoufa Aikaterini, Antoniadou Anastasia, Giamarellou Helen
| 期刊: | Antibiotics-Basel | 影响因子: | 4.600 |
| 时间: | 2025 | 起止号: | 2025 Feb 21; 14(3):223 |
| doi: | 10.3390/antibiotics14030223 | 研究方向: | 炎症/感染 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
